Display options
Share it on

Front Oncol. 2019 Apr 12;9:273. doi: 10.3389/fonc.2019.00273. eCollection 2019.

Corrigendum: Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen.

Frontiers in oncology

Joe Abdo, Christopher S Wichman, Nicholas E Dietz, Pawel Ciborowski, John Fleegel, Sumeet K Mittal, Devendra K Agrawal

Affiliations

  1. Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, United States.
  2. Department of Biostatistics, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
  3. Department of Pathology, CHI Health Creighton University Medical Center, College of Medicine, Omaha, NE, United States.
  4. Department of Pharmacology, University of Nebraska Medical Center, Omaha, NE, United States.
  5. Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Dignity Health, Phoenix, AZ, United States.

PMID: 31032230 PMCID: PMC6474362 DOI: 10.3389/fonc.2019.00273

Abstract

[This corrects the article DOI: 10.3389/fonc.2018.00157.].

Keywords: SWATH analysis; chemoresistance markers; formalin-fixed paraffin-embedded tissue; mass spectrometry; molecular oncology; proliferation markers; proteomics

Publication Types